Home LiteratureArticle Details
PMID: 10704921 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

A synthetic channel-forming peptide induces Cl(-) secretion: modulation by Ca(2+)-dependent K(+) channels.

Biochimica et biophysica acta ·Vol. 1464 ·No. 1 ·2000-03-15 ·Pages 69-82

Wallace DP, Tomich JM, Eppler JW, Iwamoto T, Grantham JJ, Sullivan LP

Abstract

A synthetic Cl(-) channel-forming peptide, C-K4-M2GlyR, applied to the apical membrane of human epithelial cell monolayers induces transepithelial Cl(-) and fluid secretion. The sequence of the core peptide, M2GlyR, corresponds to the second membrane-spanning region of the glycine receptor, a domain thought to line the pore of the ligand-gated Cl(-) channel. Using a pharmacological approach, we show that the flux of Cl(-) through the artificial Cl(-) channel can be regulated by modulating basolateral K(+) efflux through Ca(2+)-dependent K(+) channels. Application of C-K4-M2GlyR to the apical surface of monolayers composed of human colonic cells of the T84 cell line generated a sustained increase in short-circuit current (I(SC)) and caused net fluid secretion. The current was inhibited by the application of clotrimazole, a non-specific inhibitor of K(+) channels, and charybdotoxin, a potent inhibitor of Ca(2+)-dependent K(+) channels. Direct activation of these channels with 1-ethyl-2-benzimidazolinone (1-EBIO) greatly amplified the Cl(-) secretory current induced by C-K4-M2GlyR. The effect of the combination of C-K4-M2GlyR and 1-EBIO on I(SC) was significantly greater than the sum of the individual effects of the two compounds and was independent of cAMP. Treatment with 1-EBIO also increased the magnitude of fluid secretion induced by the peptide. The cooperative action of C-K4-M2GlyR and 1-EBIO on I(SC) was attenuated by Cl(-) transport inhibitors, by removing Cl(-) from the bathing solution and by basolateral treatment with K(+) channel blockers. These results indicate that apical membrane insertion of Cl(-) channel-forming peptides such as C-K4-M2GlyR and direct activation of basolateral K(+) channels with benzimidazolones may coordinate the apical Cl(-) conductance and the basolateral K(+) conductance, thereby providing a pharmacological approach to modulating Cl(-) and fluid secretion by human epithelia deficient in cystic fibrosis transmembrane conductance regulator Cl(-) channels.

MeSH Terms
Amino Acid Sequence Benzimidazoles/pharmacology Calcium/metabolism Calcium Channel Agonists/pharmacology Cell Line Chloride Channels/metabolism Chlorides/antagonists & inhibitors,metabolism Clotrimazole/pharmacology Cyclic AMP/metabolism Cystic Fibrosis/metabolism Dose-Response Relationship, Drug Drug Interactions Electric Conductivity Epithelial Cells/drug effects,metabolism Humans Intercellular Signaling Peptides and Proteins Molecular Sequence Data Peptides/pharmacology Potassium Channel Blockers Potassium Channels/metabolism
Chemicals
Benzimidazoles Calcium Channel Agonists Chloride Channels Chlorides Intercellular Signaling Peptides and Proteins K4-M2GlyR protein, synthetic Peptides Potassium Channel Blockers Potassium Channels Cyclic AMP Clotrimazole 1-ethyl-2-benzimidazolinone Calcium
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Wallace D P
Department of Molecular and Integrative Physiology, University of Kansas Medical Center, 3901 Rainbow Blvd., Kansas City, KS 66160-7401, USA. dwallace@kumc.edu
Tomich J M
Eppler J W
Iwamoto T
Grantham J J
Sullivan L P
Article Info
Journal
Biochimica et biophysica acta
Abbr.
Biochim Biophys Acta
ISSN
0006-3002
Published
2000-03-15
Pages
69-82
Language
English
Region
Netherlands
NLM ID
0217513
Subset
IM
Grants
NIDDK NIH HHS · DK-13476 · United States
NIDDK NIH HHS · DK-45614 · United States
NIGMS NIH HHS · GM-43617 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com